**

Study Overview: Observing CRYSVITA®'s Safety and Effectiveness in South Korea

** CRYSVITA® is a medicine used in South Korea to help treat certain health conditions. This study looks at how safe and effective CRYSVITA® is for patients who are already using it. It's called a "post-marketing surveillance," which means it's checking on the medicine after it has been approved and is being used by patients. The study involves injections of CRYSVITA® at doses of 10, 20, or 30mg. **Who Can Join?** Patients who have recently started using CRYSVITA® and have agreed to participate, along with their legal guardians if they're children, are eligible. However, if the drug is not safe for a patient due to specific medical reasons, they cannot join. Also, if they have used CRYSVITA® for research before it was available to the public, they are not eligible. **Key Points to Consider:** - **Length of Study**: The study duration isn't specified, but it involves routine clinical check-ups. - **Participation and Consent**: Agreement in writing is necessary for both patients and legal guardians. - **Risks and Safety**: Focuses on monitoring safety and effectiveness post-usage.

Note: Always talk to your doctor to understand if this study is right for you.